Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune ...

Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...

Stopping unnecessary cancer screenings can take over a decade after new guidelines are introduced, according to a review ...

No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

The shares of this leading pharmaceutical company are in focus after the company secured the USFDA's approval for its key ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type ...

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, ...

Cancer is costly for patients and the NHS—but it also has a significant impact on the U.K. economy, according to research led ...

Kyle MacLachlan credits wife Desiree Gruber for inspiring his work with God’s Love We Deliver, a charity aiding those with ...